Matthew Lewis
page
1
of
1
Analysis: Slow, costly process stymies generic biotech drugs
Mar 05, 2012 07:10 EST
LOS ANGELES (Reuters) - One of the pledges of the Obama administration's healthcare overhaul was to enable cheaper copies of expensive biotech drugs, but the savings may not be as deep or come as quickly as hoped.
Slow, costly process stymies generic biotech drugs
Mar 05, 2012 07:10 EST
LOS ANGELES (Reuters) - One of the pledges of the Obama administration's healthcare overhaul was to enable cheaper copies of expensive biotech drugs, but the savings may not be as deep or come as quickly as hoped.
February auto sales rise; GM posts surprise gain
Mar 01, 2012 08:56 EST
DETROIT (Reuters) - A surprising sales gain by General Motors Co <GM.N> and strong performances by Ford Motor Co <F.N> and others helped push U.S. February auto sales to their highest annual sales rate in nearly four years as consumer confidence improved and drivers gave in to the need to replace their aging cars and trucks.
February auto sales rise to highest level in 4 years
Mar 01, 2012 08:56 EST
DETROIT (Reuters) - U.S. auto sales rose nearly 16 percent in February and the annual sales rate leapt to its best level in four years, helped by a surprising sales gain by General Motors Co <GM.N> and strong results from Chrysler Group LLC and Ford Motor Co <F.N>.
February auto sales seen up slightly
Feb 29, 2012 18:34 EST
DETROIT (Reuters) - U.S. auto sales for February are expected to post a modest rise from year-earlier levels, as the industry continues its gradual recovery thanks to a rise in consumer confidence and the need to replace aging cars and trucks.
Tobacco health labels violate free speech: U.S. judge
Feb 29, 2012 15:14 EST
WASHINGTON (Reuters) - A U.S. judge sided with tobacco companies on Wednesday, ruling that a new regulation requiring large graphic health warnings on cigarette packaging and advertising violates free-speech rights under the U.S. Constitution.
Tobacco health labels violate free speech: Judge
Feb 29, 2012 15:14 EST
WASHINGTON (Reuters) - A U.S. judge sided with tobacco companies on Wednesday, ruling that a new regulation requiring large graphic health warnings on cigarette packaging and advertising violates free-speech rights under the U.S. Constitution.
Tobacco health labels unconstitutional: U.S. judge
Feb 29, 2012 15:14 EST
WASHINGTON (Reuters) - A U.S. judge sided with tobacco companies on Wednesday, ruling that regulations requiring large graphic health warnings on cigarette packaging and advertising violate free-speech rights under the U.S. Constitution.
Tobacco health labels unconstitutional: judge
Feb 29, 2012 15:14 EST
WASHINGTON (Reuters) - A U.S. judge sided with tobacco companies on Wednesday, ruling that regulations requiring large graphic health warnings on cigarette packaging and advertising violate free-speech rights under the U.S. Constitution.
"Follow the money," prosecutor tells Stanford jury
Feb 29, 2012 12:53 EST
HOUSTON (Reuters) - Allen Stanford lied to his investors and stole their money to spend on himself, a U.S. prosecutor said on Wednesday, near the end of the former financier's five-week trial on charges of criminal fraud.
Stanford swindle among history's worst: prosecutor
Feb 29, 2012 12:53 EST
HOUSTON (Reuters) - Allen Stanford perpetrated one of the biggest thefts in history, a U.S. prosecutor said on Wednesday as the former financier's trial neared its end.
Microsoft opens Windows 8 for public testing
Feb 29, 2012 11:57 EST
BARCELONA/SEATTLE (Reuters) - Microsoft Corp opened up an incomplete version of Windows 8 for the public to download and test on Wednesday, looking to rev up excitement for its slick, new-look operating system which it hopes will restore its fading tech supremacy.
Microsoft releases Windows 8 for public testing
Feb 29, 2012 11:57 EST
BARCELONA/SEATTLE (Reuters) - Microsoft Corp released an incomplete version of Windows 8 for the public to download and try out on Wednesday, looking to rev up excitement for the slick, new-look operating system that it hopes will restore its fading tech supremacy.
Moody's must face whistleblower analyst's claim
Feb 28, 2012 16:21 EST
(Reuters) - The parent of Moody's Investors Service was ordered to defend against a lawsuit by a former analyst who claimed it retaliated improperly against him after he called into question its credit ratings for debt securities that later proved toxic.
CME Group reveals subpoenas in MF Global probe
Feb 28, 2012 09:55 EST
CHICAGO (Reuters) - CME Group Inc received two subpoenas, including one for a criminal probe, in the immediate aftermath of the collapse of futures broker MF Global Holdings Ltd, the giant exchange operator said on Tuesday.
JPMorgan aims to use size to lift profit by 25 percent
Feb 28, 2012 09:51 EST
(Reuters) - JPMorgan Chase & Co <JPM.N> plans to use size to its advantage, leveraging the various components of its business to help increase annual earnings more than 25 percent over time, the bank's executives said on Tuesday.
Stanford defense rests without calling Stanford
Feb 27, 2012 17:19 EST
HOUSTON (Reuters) - Texas financier Allen Stanford's attorneys wound up their defense in his criminal fraud trial on Monday without calling Stanford himself to testify.
Apple tactics in China iPad deal unusual: experts
Feb 24, 2012 18:39 EST
SAN FRANCISCO (Reuters) - Proview Electronics, the firm trying to stop Apple Inc from using the iPad name in China, has a plausible claim over the unusual methods Apple used to conceal its identity when attempting to acquire Proview's trademarks, according to several legal experts.
Hedge fund nominates five for AOL board
Feb 24, 2012 14:33 EST
(Reuters) - Activist hedge fund Starboard Value LP nominated a slate of five candidates to AOL Inc's board, saying discussions with the company in the past two months were unsatisfying.
Boeing names new head of 787 program
Feb 24, 2012 14:21 EST
(Reuters) - Boeing Co <BA.N> said it swapped the heads of its 787 Dreamliner and 777 programs, tapping the skills of the long-time 777 leader to ensure the delayed Dreamliner program hits a production rate target that many experts believe is unrealistic.
